Betraying their importance as malignant activators in pediatric T-ALL patients, we observed similarly raised frequencies of aberrant NKX3-2 (~18%) and TLX3 (~22%) but somewhat lower patient counts affecting TLX1 (7%), demonstrating a frequent involvement of this subclass member in this malignancy in children. Here, NKX3-2 is linked to acute lymphoblastic leukemia.